TG Therapeutics Inc
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | 3.6 | – | – | – | – | – | – | – | – | – | – | – | – | 200.4 | 206.4 | 10.8 | |
| 178.1 | 207.2 | 2.3 | 5.8 | 0.8 | 1.6 | 7.5 | – | – | – | – | – | – | – | – | – | 2,478.5 | 650.4 | 3,532.5 | 3,564.7 | 1,512.6 | 3,340.1 | 2,035.6 | 6,453.3 | 39,456.3 | 375.6 | 573.7 | 10.9 | 14.7 | 7.8 | |
| 8.5 | 2.5 | 1.1 | 2.0 | 8.1 | 3.6 | – | 5.2 | 5.9 | 5.9 | 30.8 | – | – | – | – | 0.2 | 3.0 | 2.5 | 6.7 | 5.3 | 6.4 | 7.6 | 12.9 | 25.4 | 11.5 | 10.6 | 27.3 | 15.8 | 21.7 | 7.4 | |
| – | – | – | – | – | – | 8.9 | – | – | – | – | – | – | – | – | – | 1,780.3 | 389.6 | 3,168.7 | 3,204.7 | 1,348.8 | 2,968.7 | 1,760.0 | 5,913.4 | 36,022.9 | 341.2 | 563.1 | 10.9 | 14.9 | 8.1 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | 10.5 | – | – | – | – | – | – | – | – | – | – | – | – | 97.6 | 98.0 | 37.0 | |
| -23.0% | -20.7% | -41.5% | -34.7% | -32.8% | -102.5% | -38.3% | -9.7% | -22.3% | -11.1% | -16.8% | -167.3% | -630.5% | -18.6% | -88.2% | -4.0% | -11.0% | -10.9% | -6.5% | -8.2% | -26.9% | -18.4% | -41.7% | -13.6% | -3.6% | -11.8% | -11.0% | -1.2% | -0.8% | -0.5% | |
| Margins | ||||||||||||||||||||||||||||||
| 100.0% | 200.0% | 106.7% | 33.3% | 24.3% | 23.2% | 100.0% | – | – | – | – | – | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 42.1% | 100.0% | 100.0% | 88.2% | 90.5% | 94.0% | 88.3% | 83.7% | |
| -3,800.0% | -5,300.0% | -90.0% | -225.0% | -59.0% | -114.6% | -310.6% | – | – | – | – | – | – | – | – | – | -141,196.4% | -15,071.4% | -36,567.0% | -41,461.9% | -51,823.5% | -77,904.6% | -114,736.8% | -111,220.4% | -179,996.1% | -5,154.3% | -7,839.0% | 8.8% | 12.7% | 20.0% | |
| -3,600.0% | -5,200.0% | -93.3% | -200.0% | -108.3% | -64.0% | -309.4% | – | – | – | – | – | – | – | – | – | -94,879.9% | -13,438.8% | -36,606.5% | -41,310.0% | -51,353.4% | -77,749.9% | -114,132.9% | -113,730.9% | -183,803.3% | -5,204.1% | -8,036.3% | 5.4% | 7.1% | 72.6% | |
| -4,100.0% | -4,300.0% | -93.3% | -200.0% | -24.7% | -169.0% | -287.6% | – | – | – | – | – | – | – | – | – | -27,243.6% | -7,107.1% | -23,020.3% | -29,355.7% | -40,645.0% | -61,533.8% | -84,878.3% | -87,458.6% | -141,357.9% | -4,425.7% | -6,326.2% | -13.4% | -12.3% | -4.1% | |
| Returns | ||||||||||||||||||||||||||||||
| -171.4% | -61.9% | -47.5% | -70.6% | -1,169.7% | -138.8% | – | -87.2% | -132.4% | -200.6% | -644.4% | – | – | – | – | -8.9% | -116.2% | -51.1% | -69.6% | -62.0% | -218.2% | -176.8% | -721.8% | -447.7% | -53.8% | -146.8% | -382.0% | 7.9% | 10.5% | 69.0% | |
| -150.0% | -59.1% | -43.1% | -60.0% | -182.7% | -98.7% | -616.9% | -76.4% | -104.4% | -170.8% | -281.2% | -1,227.1% | -341.8% | -763.9% | 3.3% | -5.4% | -81.9% | -42.6% | -64.3% | -55.5% | -142.8% | -121.7% | -207.5% | -106.0% | -44.7% | -91.7% | -115.6% | 3.8% | 4.0% | 42.1% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||
| – | – | – | – | – | – | 0.7 | – | – | – | – | – | 1.1 | 1.9 | 18 | -4.9 | -13 | -40 | -55 | -55 | -25 | -57 | -42 | -82 | -522 | -230 | -30 | 8.6 | 66 | 168 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | 9.3 | – | – | – | – | – | – | – | – | – | – | – | – | 0.3 | 1.3 | 1.2 | |
| 87.5% | 95.5% | 90.8% | 85.0% | 15.6% | 71.1% | -130.4% | 87.6% | 78.8% | 85.1% | 43.6% | -90.9% | -350.4% | -1,855.5% | -28.8% | 60.5% | 70.4% | 83.3% | 92.3% | 89.5% | 65.5% | 68.8% | 28.7% | 23.7% | 83.0% | 62.5% | 30.3% | 48.7% | 38.5% | 60.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.5 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.8 | 0.1 | 0.3 | 1.2 | 0.6 | 1.1 | 0.4 | |
| Per Share | ||||||||||||||||||||||||||||||
| -17,391.30 | -23,853.21 | -8,750.00 | -7,017.54 | -13,339.03 | -1,528.59 | -347.70 | -748.86 | -615.64 | -1,236.34 | -453.62 | -497.55 | -170.00 | -111.24 | 15.68 | -0.44 | -1.38 | -0.81 | -1.64 | -1.38 | -1.60 | -1.91 | -2.30 | -1.96 | -2.42 | -2.63 | -1.65 | 0.09 | 0.15 | 2.77 | |
| 483.09 | 458.72 | 9,375.00 | 3,508.77 | 12,319.42 | 2,389.36 | 112.38 | – | – | – | – | – | – | – | – | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 | 0.02 | 1.57 | 2.05 | 3.82 | |
| 10,144.93 | 38,532.11 | 18,437.50 | 9,941.52 | 1,140.37 | 1,101.09 | -73.50 | 858.41 | 465.05 | 616.23 | 70.40 | -36.85 | -174.26 | -270.20 | -134.86 | 5.00 | 1.19 | 1.58 | 2.35 | 2.23 | 0.73 | 1.08 | 0.32 | 0.44 | 4.50 | 1.79 | 0.43 | 1.08 | 1.39 | 4.01 | |
| -19,806.76 | -19,724.77 | -8,750.00 | -7,017.54 | -3,044.59 | -4,037.55 | -323.22 | -434.43 | -608.62 | -405.92 | -364.38 | -423.39 | -177.33 | -41.81 | -49.60 | -0.04 | -0.40 | -0.43 | -1.03 | -0.98 | -1.26 | -1.51 | -1.71 | -1.50 | -1.86 | -2.24 | -1.30 | -0.21 | -0.25 | -0.15 | |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.